What services does JCC Group provide for pharmaceutical and biologics manufacturers?

JCC Group offers end-to-end regulatory consulting services for pharmaceutical and biologics companies, including 21 CFR Part 211 cGMP compliance, Quality Management System (QMS) design, validation strategy, FDA inspection readiness, supplier qualification, data integrity assessments, and harmonization with ICH international standards (Q7, Q8, Q9, Q10, and Q11). Our consultants partner with clients across the full product lifecycle — from facility start-up and clinical-stage manufacturing through commercial production and post-approval changes.

What types of companies does JCC Group work with?

We support a broad spectrum of clients, including emerging biotech startups, contract manufacturers (CMOs/CDMOs), mid-size pharmaceutical companies, global drug manufacturers, biologics and cell & gene therapy developers, and international manufacturers exporting to the U.S. market. Whether you are launching your first product or managing a multi-site global operation, our services scale to fit your needs.

What is 21 CFR Part 211, and who must comply?

21 CFR Part 211 establishes the FDA's Current Good Manufacturing Practice (cGMP) requirements for finished pharmaceuticals. It applies to any company involved in manufacturing, processing, packaging, labeling, or holding human and veterinary drug products distributed in the United States — including drug substance and drug product manufacturers, contract facilities, and repackagers.

How does JCC Group help companies achieve 21 CFR Part 211 compliance?

We provide comprehensive support including cGMP gap assessments, QMS design and implementation, SOP and documentation development, equipment qualification (IQ/OQ/PQ), process and cleaning validation, quality control laboratory compliance, change control programs, CAPA systems, and mock FDA inspections. Our team builds compliance programs tailored to your operations — not generic templates.

Does JCC Group support biologics manufacturers under 21 CFR Part 211?

Yes. While biologics are also governed by 21 CFR Part 600-series regulations, Part 211 still applies to many aspects of biologic drug product manufacturing. We support biologics manufacturers across monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, and biosimilars — addressing both small-molecule and large-molecule complexities.

What are ICH guidelines, and why do they matter?

The International Council for Harmonisation (ICH) develops globally recognized standards for pharmaceutical quality, safety, and efficacy. Compliance with ICH guidelines — especially Q7 (API GMP), Q8 (Pharmaceutical Development), Q9 (Quality Risk Management), Q10 (Pharmaceutical Quality System), and Q11 (Drug Substance Development) — is essential for companies seeking global market access and harmonized regulatory approval across the U.S., EU, Japan, and other ICH regions.

How does JCC Group help companies align with ICH standards?

Our consultants integrate ICH principles into every aspect of our consulting work. We design Pharmaceutical Quality Systems aligned with ICH Q10, implement quality risk management frameworks per ICH Q9, support development activities under Q8/Q11, and ensure API manufacturing aligns with ICH Q7 — enabling clients to meet both FDA expectations and global harmonized requirements simultaneously.

Can JCC Group build a Quality Management System (QMS) from scratch?

Absolutely. We design and implement complete Quality Management Systems for new facilities, startups, and companies transitioning from clinical-stage to commercial manufacturing. Our QMS deliverables include Quality Manuals, SOPs, work instructions, forms, Master Production Records, Batch Production Records, change control systems, and integrated documentation control platforms.

Does JCC Group provide ongoing QMS maintenance and support?

Yes. Beyond initial implementation, we offer long-term advisory services to keep your QMS current with evolving regulations, support periodic management reviews, conduct internal audits, manage CAPA effectiveness checks, and provide regulatory intelligence updates. Many clients engage us as their long-term regulatory partner rather than a one-time consultant.

What happens during a mock FDA inspection conducted by JCC Group?

Our mock inspections replicate real FDA methodology — including facility walkthroughs, document reviews, employee interviews, and front-room/back-room dynamics. We assess your operations against 21 CFR Part 211, your QMS, and applicable ICH standards, then deliver a detailed report with prioritized findings, root cause insights, and clear remediation recommendations.

Can JCC Group help if we received a Form 483 or FDA Warning Letter?

Yes — rapid-response remediation is one of our core specialties. Our team conducts immediate root cause investigations, develops comprehensive CAPA plans, drafts written responses that meet FDA expectations, and manages the remediation process from start to finish. We have helped clients successfully close significant findings and restore compliance under tight deadlines.

EU-TPD Notifications - J&J Consulting Group- FDA Regulatory Compliance

European Tobacco

EU tobacco directive

The European Tobacco Product Directive (ETPD) regulates the manufacture, marketing, labeling, and sale of tobacco and related products across the EU, ensuring public health protection and market compliance.

Call for Appoinment

+ 1 949 390 5684

99%

Satisfy client

Years of Experience

0 +

ETPD Overview

What is ETPD?

European Tobacco Products Directive (EUTPD) (2014/40/EU) is a directive of the European Union that places limits on the sale and marketing of tobacco and tobacco-related products in the EU. The TPD aims to improve the functioning of the internal market for tobacco and related products while ensuring a high level of health protection for European citizens. Based on the proposal of the European Commission, the Directive entered into force on 19 May 2014 and became applicable in the EU Member States on 20 May 2016.

This Directive applies to the manufacture, presentation, and sale of tobacco-related products, including cigarettes, roll your own tobacco, pipe tobacco, cigars, cigarillos, smokeless tobacco, electronic cigarettes, and herbal products for smoking. The European Union and its Member States have taken various tobacco control measures in the form of legislation, recommendations, and information campaigns. The European Union

Rules govern the aspects of tobacco sales and require the tobacco industry to submit detailed reports to the Member States with the ingredients used in tobacco products (including the health warnings that appear on packages of tobacco and related products).

The policies of the Tobacco Products Directive are; the regulation of tobacco products on the EU market (e.g. packaging, labeling, and ingredients), advertising restrictions for tobacco products, the creation of smoke-free environments, tax measures, and activities against illegal trade, and acquiring anti-smoking campaigns.

ETPD Guidelines

Tobacco sales rules and regulatory compliance policies

Years Of Research

0 +

Satisfaction Rate

0 %

Medical Partner

0 +

Our Support

How can we support

JJCC Group has helped many of our clients and prepared and submitted 1000s notificiations to the EU-TPD and UK-MHRA. Our services include:

Company & product registration

Registration of company and product with the EU-TPD and UK-MHRA

Review of labeling product

Information, contents, and warning to ensure compliance with standard EU-TPD and UK-MHRA requirements

Health risk assessment

Prepare a health and toxicology assessment for ingredients/chemicals (CAS).

Testing and analysis services

Establish, and facilitate required testing and analysis.

Regulatory submission services

Submission to EU-TPD and UK-MHRA portals

Follow up with submission

Registration for individual European countries.

Ongoing compliance monitoring

Provide continuous support updates.

Full eu-tpd and uk-mhra tobacco compliance support

Get started today

Ensure full eu-tpd tobacco today

Ensure your tobacco products fully comply with EU-TPD and UK-MHRA regulations. Contact JJCC Group for registration, submissions, testing, and ongoing compliance support.

Best Compliance with 5 Star

99% Happy Clients

Testimonial

What our clients say about JJCC

Clients trust JJCC Group for expert FDA CGMP guidance, ensuring compliant, high-quality drug and biologics manufacturing.

JJCC streamlined our CGMP compliance process, making FDA audits easier and improving overall manufacturing quality.

Sarah Bennett OWNER

Absolutely! Their expertise in regulatory guidance and training has been invaluable for our drug and biologics operations.

Bts Ashik OWNER

Their team provides consistent, professional support, ensuring our facility maintains full compliance and operational excellence.

Shadin De Manager

Faqs

Frequently asked questions

Our Frequently Asked Questions provide clear guidance on EU-TPD and UK-MHRA compliance, covering registration, labeling, testing, submissions, and ongoing regulatory requirements for tobacco products.

These answers help businesses understand obligations, reduce risks, and maintain compliant, safe, and market-ready products across European markets.

What is the EU Tobacco Product Directive?

The EUTPD regulates the manufacture, labeling, marketing, and sale of tobacco products across the EU to ensure public health protection.

Who must comply with EU-TPD?

All tobacco manufacturers, importers, and distributors selling products in the EU must comply with EU-TPD and UK-MHRA regulations.

What products are covered under EU-TPD?

Cigarettes, roll-your-own tobacco, pipe tobacco, cigars, cigarillos, smokeless tobacco, e-cigarettes, and herbal smoking products.

How can JJCC Group assist with compliance?

We handle company/product registration, labeling review, health assessments, testing, submissions, and country-specific registration across the EU.

Is ongoing monitoring necessary?

Yes, continuous compliance monitoring ensures adherence to regulations, prevents violations, and keeps products legally marketable in Europe.